The Role of the Glutathione System in Oxidative Modification of Proteins and Dysregulation of Apoptosis in Jurkat Tumor Cells
We compared changes in the redox status and intensity of oxidative modification of proteins in intact Jurkat tumor cells and cells cultured with buthionine sulfoximine, an inhibitor of the key enzyme of glutathione synthesis γ-glutamylcysteine synthetase. The glutathione system components play a rol...
Gespeichert in:
Veröffentlicht in: | Bulletin of experimental biology and medicine 2017-12, Vol.164 (2), p.199-202 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 202 |
---|---|
container_issue | 2 |
container_start_page | 199 |
container_title | Bulletin of experimental biology and medicine |
container_volume | 164 |
creator | Nosareva, O. L. Stepovaya, E. A. Ryazantseva, N. V. Shakhristova, E. V. Egorova, M. Yu Novitsky, V. V. |
description | We compared changes in the redox status and intensity of oxidative modification of proteins in intact Jurkat tumor cells and cells cultured with buthionine sulfoximine, an inhibitor of the key enzyme of glutathione synthesis γ-glutamylcysteine synthetase. The glutathione system components play a role in modulation of the content of protein-bound glutathione, protein carbonyl derivatives, bityrosine, and oxidized tryptophan, and in dysregulation of apoptosis in Jurkat tumor cells. Inhibition of
de novo
synthesis of glutathione in Jurkat tumor cells was followed by accumulation of hydroxyl radical, a reduction in the level of protein-bound glutathione and oxidized tryptophan, and a rise in the concentration of protein carbonyl derivatives. These changes were accompanied by activation of programmed cell death. |
doi_str_mv | 10.1007/s10517-017-3957-x |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1969936058</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A525184718</galeid><sourcerecordid>A525184718</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-9d21598dfaafdc9bca98ec4c622c777bf5869e965e8e3c2dd8f7003467c235393</originalsourceid><addsrcrecordid>eNp1kl1vFCEYhYnR2G31B3hjSExMb6YCMwxwuVm1ampqdL0mLB-71JlhBcbsXvjfZdy1aY2GEL6ecwIvB4BnGF1ghNirhBHFrEKl14KyavcAzDBldcUJwQ_BDBWoajjnJ-A0pZtpiVr8GJwQgRnjrJmBn8uNhZ9DZ2FwMJf5ZTdmlTc-DBZ-2adse-gHeL3zRmX_w8KPwXjndVmEYdJ8iiFbPySoBgNf71O067G7PZ1vwzaH5NNk8mGM31SGy7EPES5s16Un4JFTXbJPj-MZ-Pr2zXLxrrq6vny_mF9VumEoV8IQTAU3TilntFhpJbjVjW4J0YyxlaO8FVa01HJba2IMdwyhummZJjWtRX0Gzg--2xi-jzZl2fukyw3UYMOYJBatEHWLKC_oi7_QmzDGodxuojgRtPlteKTWqrPSDy7kqPRkKueUUMwbhievi39QpRnbe10q7HzZvyd4eUewsarLmxTKj5RypvsgPoA6hlRq7uQ2-l7FvcRITtmQh2zIkg05ZUPuiub58WXjqrfmVvEnDAUgByCVo2Ft452n_9f1FwUsw1g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1968295439</pqid></control><display><type>article</type><title>The Role of the Glutathione System in Oxidative Modification of Proteins and Dysregulation of Apoptosis in Jurkat Tumor Cells</title><source>MEDLINE</source><source>SpringerLink (Online service)</source><creator>Nosareva, O. L. ; Stepovaya, E. A. ; Ryazantseva, N. V. ; Shakhristova, E. V. ; Egorova, M. Yu ; Novitsky, V. V.</creator><creatorcontrib>Nosareva, O. L. ; Stepovaya, E. A. ; Ryazantseva, N. V. ; Shakhristova, E. V. ; Egorova, M. Yu ; Novitsky, V. V.</creatorcontrib><description>We compared changes in the redox status and intensity of oxidative modification of proteins in intact Jurkat tumor cells and cells cultured with buthionine sulfoximine, an inhibitor of the key enzyme of glutathione synthesis γ-glutamylcysteine synthetase. The glutathione system components play a role in modulation of the content of protein-bound glutathione, protein carbonyl derivatives, bityrosine, and oxidized tryptophan, and in dysregulation of apoptosis in Jurkat tumor cells. Inhibition of
de novo
synthesis of glutathione in Jurkat tumor cells was followed by accumulation of hydroxyl radical, a reduction in the level of protein-bound glutathione and oxidized tryptophan, and a rise in the concentration of protein carbonyl derivatives. These changes were accompanied by activation of programmed cell death.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-017-3957-x</identifier><identifier>PMID: 29177874</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Apoptosis ; Apoptosis - drug effects ; Biomedical and Life Sciences ; Biomedicine ; Buthionine sulfoximine ; Buthionine Sulfoximine - pharmacology ; Cell activation ; Cell Biology ; Cell death ; Enzyme Inhibitors - pharmacology ; Gene Expression ; Glutamate-Cysteine Ligase - antagonists & inhibitors ; Glutamate-Cysteine Ligase - genetics ; Glutamate-Cysteine Ligase - metabolism ; Glutathione ; Glutathione - antagonists & inhibitors ; Glutathione - metabolism ; Humans ; Hydroxides ; Hydroxyl Radical - agonists ; Hydroxyl Radical - metabolism ; Hydroxyl radicals ; Internal Medicine ; Jurkat Cells ; Laboratory Medicine ; Ligases ; Oxidation-Reduction ; Oxidative stress ; Oxidative Stress - drug effects ; Pathology ; Protein binding ; Protein Carbonylation - drug effects ; Proteins ; Thiols ; Tryptophan ; Tryptophan - metabolism ; Tumor cells ; Tumors ; Tyrosine - analogs & derivatives ; Tyrosine - metabolism ; γ-Glutamylcysteine</subject><ispartof>Bulletin of experimental biology and medicine, 2017-12, Vol.164 (2), p.199-202</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2017</rights><rights>COPYRIGHT 2017 Springer</rights><rights>Bulletin of Experimental Biology and Medicine is a copyright of Springer, (2017). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-9d21598dfaafdc9bca98ec4c622c777bf5869e965e8e3c2dd8f7003467c235393</citedby><cites>FETCH-LOGICAL-c470t-9d21598dfaafdc9bca98ec4c622c777bf5869e965e8e3c2dd8f7003467c235393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10517-017-3957-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10517-017-3957-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29177874$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nosareva, O. L.</creatorcontrib><creatorcontrib>Stepovaya, E. A.</creatorcontrib><creatorcontrib>Ryazantseva, N. V.</creatorcontrib><creatorcontrib>Shakhristova, E. V.</creatorcontrib><creatorcontrib>Egorova, M. Yu</creatorcontrib><creatorcontrib>Novitsky, V. V.</creatorcontrib><title>The Role of the Glutathione System in Oxidative Modification of Proteins and Dysregulation of Apoptosis in Jurkat Tumor Cells</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>We compared changes in the redox status and intensity of oxidative modification of proteins in intact Jurkat tumor cells and cells cultured with buthionine sulfoximine, an inhibitor of the key enzyme of glutathione synthesis γ-glutamylcysteine synthetase. The glutathione system components play a role in modulation of the content of protein-bound glutathione, protein carbonyl derivatives, bityrosine, and oxidized tryptophan, and in dysregulation of apoptosis in Jurkat tumor cells. Inhibition of
de novo
synthesis of glutathione in Jurkat tumor cells was followed by accumulation of hydroxyl radical, a reduction in the level of protein-bound glutathione and oxidized tryptophan, and a rise in the concentration of protein carbonyl derivatives. These changes were accompanied by activation of programmed cell death.</description><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Buthionine sulfoximine</subject><subject>Buthionine Sulfoximine - pharmacology</subject><subject>Cell activation</subject><subject>Cell Biology</subject><subject>Cell death</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Gene Expression</subject><subject>Glutamate-Cysteine Ligase - antagonists & inhibitors</subject><subject>Glutamate-Cysteine Ligase - genetics</subject><subject>Glutamate-Cysteine Ligase - metabolism</subject><subject>Glutathione</subject><subject>Glutathione - antagonists & inhibitors</subject><subject>Glutathione - metabolism</subject><subject>Humans</subject><subject>Hydroxides</subject><subject>Hydroxyl Radical - agonists</subject><subject>Hydroxyl Radical - metabolism</subject><subject>Hydroxyl radicals</subject><subject>Internal Medicine</subject><subject>Jurkat Cells</subject><subject>Laboratory Medicine</subject><subject>Ligases</subject><subject>Oxidation-Reduction</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Pathology</subject><subject>Protein binding</subject><subject>Protein Carbonylation - drug effects</subject><subject>Proteins</subject><subject>Thiols</subject><subject>Tryptophan</subject><subject>Tryptophan - metabolism</subject><subject>Tumor cells</subject><subject>Tumors</subject><subject>Tyrosine - analogs & derivatives</subject><subject>Tyrosine - metabolism</subject><subject>γ-Glutamylcysteine</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kl1vFCEYhYnR2G31B3hjSExMb6YCMwxwuVm1ampqdL0mLB-71JlhBcbsXvjfZdy1aY2GEL6ecwIvB4BnGF1ghNirhBHFrEKl14KyavcAzDBldcUJwQ_BDBWoajjnJ-A0pZtpiVr8GJwQgRnjrJmBn8uNhZ9DZ2FwMJf5ZTdmlTc-DBZ-2adse-gHeL3zRmX_w8KPwXjndVmEYdJ8iiFbPySoBgNf71O067G7PZ1vwzaH5NNk8mGM31SGy7EPES5s16Un4JFTXbJPj-MZ-Pr2zXLxrrq6vny_mF9VumEoV8IQTAU3TilntFhpJbjVjW4J0YyxlaO8FVa01HJba2IMdwyhummZJjWtRX0Gzg--2xi-jzZl2fukyw3UYMOYJBatEHWLKC_oi7_QmzDGodxuojgRtPlteKTWqrPSDy7kqPRkKueUUMwbhievi39QpRnbe10q7HzZvyd4eUewsarLmxTKj5RypvsgPoA6hlRq7uQ2-l7FvcRITtmQh2zIkg05ZUPuiub58WXjqrfmVvEnDAUgByCVo2Ft452n_9f1FwUsw1g</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Nosareva, O. L.</creator><creator>Stepovaya, E. A.</creator><creator>Ryazantseva, N. V.</creator><creator>Shakhristova, E. V.</creator><creator>Egorova, M. Yu</creator><creator>Novitsky, V. V.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20171201</creationdate><title>The Role of the Glutathione System in Oxidative Modification of Proteins and Dysregulation of Apoptosis in Jurkat Tumor Cells</title><author>Nosareva, O. L. ; Stepovaya, E. A. ; Ryazantseva, N. V. ; Shakhristova, E. V. ; Egorova, M. Yu ; Novitsky, V. V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-9d21598dfaafdc9bca98ec4c622c777bf5869e965e8e3c2dd8f7003467c235393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Buthionine sulfoximine</topic><topic>Buthionine Sulfoximine - pharmacology</topic><topic>Cell activation</topic><topic>Cell Biology</topic><topic>Cell death</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Gene Expression</topic><topic>Glutamate-Cysteine Ligase - antagonists & inhibitors</topic><topic>Glutamate-Cysteine Ligase - genetics</topic><topic>Glutamate-Cysteine Ligase - metabolism</topic><topic>Glutathione</topic><topic>Glutathione - antagonists & inhibitors</topic><topic>Glutathione - metabolism</topic><topic>Humans</topic><topic>Hydroxides</topic><topic>Hydroxyl Radical - agonists</topic><topic>Hydroxyl Radical - metabolism</topic><topic>Hydroxyl radicals</topic><topic>Internal Medicine</topic><topic>Jurkat Cells</topic><topic>Laboratory Medicine</topic><topic>Ligases</topic><topic>Oxidation-Reduction</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Pathology</topic><topic>Protein binding</topic><topic>Protein Carbonylation - drug effects</topic><topic>Proteins</topic><topic>Thiols</topic><topic>Tryptophan</topic><topic>Tryptophan - metabolism</topic><topic>Tumor cells</topic><topic>Tumors</topic><topic>Tyrosine - analogs & derivatives</topic><topic>Tyrosine - metabolism</topic><topic>γ-Glutamylcysteine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nosareva, O. L.</creatorcontrib><creatorcontrib>Stepovaya, E. A.</creatorcontrib><creatorcontrib>Ryazantseva, N. V.</creatorcontrib><creatorcontrib>Shakhristova, E. V.</creatorcontrib><creatorcontrib>Egorova, M. Yu</creatorcontrib><creatorcontrib>Novitsky, V. V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nosareva, O. L.</au><au>Stepovaya, E. A.</au><au>Ryazantseva, N. V.</au><au>Shakhristova, E. V.</au><au>Egorova, M. Yu</au><au>Novitsky, V. V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of the Glutathione System in Oxidative Modification of Proteins and Dysregulation of Apoptosis in Jurkat Tumor Cells</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>164</volume><issue>2</issue><spage>199</spage><epage>202</epage><pages>199-202</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><abstract>We compared changes in the redox status and intensity of oxidative modification of proteins in intact Jurkat tumor cells and cells cultured with buthionine sulfoximine, an inhibitor of the key enzyme of glutathione synthesis γ-glutamylcysteine synthetase. The glutathione system components play a role in modulation of the content of protein-bound glutathione, protein carbonyl derivatives, bityrosine, and oxidized tryptophan, and in dysregulation of apoptosis in Jurkat tumor cells. Inhibition of
de novo
synthesis of glutathione in Jurkat tumor cells was followed by accumulation of hydroxyl radical, a reduction in the level of protein-bound glutathione and oxidized tryptophan, and a rise in the concentration of protein carbonyl derivatives. These changes were accompanied by activation of programmed cell death.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>29177874</pmid><doi>10.1007/s10517-017-3957-x</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-4888 |
ispartof | Bulletin of experimental biology and medicine, 2017-12, Vol.164 (2), p.199-202 |
issn | 0007-4888 1573-8221 |
language | eng |
recordid | cdi_proquest_miscellaneous_1969936058 |
source | MEDLINE; SpringerLink (Online service) |
subjects | Apoptosis Apoptosis - drug effects Biomedical and Life Sciences Biomedicine Buthionine sulfoximine Buthionine Sulfoximine - pharmacology Cell activation Cell Biology Cell death Enzyme Inhibitors - pharmacology Gene Expression Glutamate-Cysteine Ligase - antagonists & inhibitors Glutamate-Cysteine Ligase - genetics Glutamate-Cysteine Ligase - metabolism Glutathione Glutathione - antagonists & inhibitors Glutathione - metabolism Humans Hydroxides Hydroxyl Radical - agonists Hydroxyl Radical - metabolism Hydroxyl radicals Internal Medicine Jurkat Cells Laboratory Medicine Ligases Oxidation-Reduction Oxidative stress Oxidative Stress - drug effects Pathology Protein binding Protein Carbonylation - drug effects Proteins Thiols Tryptophan Tryptophan - metabolism Tumor cells Tumors Tyrosine - analogs & derivatives Tyrosine - metabolism γ-Glutamylcysteine |
title | The Role of the Glutathione System in Oxidative Modification of Proteins and Dysregulation of Apoptosis in Jurkat Tumor Cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T14%3A22%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20the%20Glutathione%20System%20in%20Oxidative%20Modification%20of%20Proteins%20and%20Dysregulation%20of%20Apoptosis%20in%20Jurkat%20Tumor%20Cells&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Nosareva,%20O.%20L.&rft.date=2017-12-01&rft.volume=164&rft.issue=2&rft.spage=199&rft.epage=202&rft.pages=199-202&rft.issn=0007-4888&rft.eissn=1573-8221&rft_id=info:doi/10.1007/s10517-017-3957-x&rft_dat=%3Cgale_proqu%3EA525184718%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1968295439&rft_id=info:pmid/29177874&rft_galeid=A525184718&rfr_iscdi=true |